)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Medivir
Medivir (MVIR) investor relations material
Medivir Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary18 Feb, 2026
Executive summary
SEK 151 million rights issue and SEK 45 million directed share issue strengthened the financial position, enabling advancement of MIV-711 for Osteogenesis Imperfecta and fostrox for liver cancer, both with significant market potential.
MIV-711 received FDA Orphan Drug Designation for Osteogenesis Imperfecta; phase II proof-of-concept study underway, targeting a high unmet need with no approved systemic treatments.
Fostrox program in liver cancer advancing, with finalized study design and collaboration with major Korean hospitals; top-line results expected in 2027.
VBX-1000 (MIV-701) for canine periodontitis shows promising proof-of-concept data; randomized, placebo-controlled study initiated, with results expected Q4 2026.
Out-licensing of remetinostat to Biossil, with potential milestone payments up to USD 60 million and future royalties.
Financial highlights
Q4 net turnover was SEK 5.5 million, up from SEK 1.0 million year-over-year, mainly due to remetinostat licensing revenue and royalty income from Xerclear.
Operating loss for Q4 was SEK -42.5 million, higher year-over-year due to a SEK 29.8 million non-cash write-down on the birinapant project.
Cash flow from operating activities in Q4 was approximately SEK -6.3 million.
Year-end cash balance was SEK 119.2 million, up from SEK 62.5 million, bolstered by rights and directed share issues.
Full-year net turnover reached SEK 8.5 million, up from SEK 3.5 million in 2024.
Outlook and guidance
Cash runway extends into 2028, sufficient to fund planned phase II studies in both liver cancer and Osteogenesis Imperfecta under current assumptions.
MIV-711 phase II study in OI expected to enroll quickly due to pre-identified patient populations; pivotal phase to follow proof-of-concept.
Fostrox study in Korea expected to generate top-line results in 2027.
VBX-1000 animal health study results expected Q4 2026.
No dividend proposed for 2025.
MIV-711 commercialization strategy post-ODD
MIV-701 royalty revenue impact on valuation
Strategy for Birinapant and USP-1/7 assets
MIV-711 OI: patient population for Phase II
Fostrox: how will patient enrollment be expedited?
VBX-1000: Basis for blockbuster potential
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Medivir earnings date
Q1 202629 Apr, 2026
Medivir
Next Medivir earnings date
Q1 202629 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Medivir AB researches, develops, and sells pharmaceuticals primarily for the treatment of oncology in Sweden and internationally. It focuses on targeted therapies and vaccines. The company offers Merivo alfa, a product that has completed late stage clinical trials; MIV-711, which has completed phase I/II clinical trials; MIV-102 that has completed phase I/II clinical trial; and other projects in various phases of clinical development. Medivir AB was founded in 1987 and is headquartered in Huddinge, Sweden.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage